Australian Trachoma Surveillance Report 2023
DOI:
https://doi.org/10.33321/cdi.2026.50.009Keywords:
trachoma, SAFE control strategy, surveillance, eliminationAbstract
Trachoma is the world’s leading infectious cause of preventable blindness and is linked to poor living conditions. Australia has remained the only high-income country where trachoma is endemic, primarily in remote Indigenous communities in the Northern Territory, South Australia and Western Australia. The Australian Government funds the National Trachoma Surveillance and Reporting Unit to analyse surveillance data annually to assess progress against World Health Organization (WHO) criteria for the elimination of trachoma as a public health problem. These criteria include (i) prevalence of trachomatous inflammation–follicular less than 5% in children aged 1–9 years; and (ii) prevalence of trachomatous trichiasis ‘unknown to the health system’ of less than 0.2% in persons aged 15 years and above. Australia first reached these thresholds in 2022 and must maintain these levels in each formerly endemic jurisdiction (state/territory) for a further two years before being eligible to apply to the WHO for validation of elimination of trachoma as a public health problem. In 2023, screening staff used WHO grading criteria to assess trachoma in 67 at-risk communities. Overall prevalence, which includes estimates from all communities ever considered at risk, remained below 5% in 2023 at 2.3% in the Northern Territory; 0% in South Australia; and 1.6% in Western Australia. The proportion of new trachomatous trichiasis cases was 0.01% in the Northern Territory; 0% in South Australia; and 0.2% in Western Australia. Australia is on track to eliminate trachoma as a public health problem; however, the disease remains a health issue in some remote Indigenous communities.
Downloads
References
World Health Organization (WHO), WHO Alliance for the Global Elimination of Trachoma. Progress report on elimination of trachoma, 2023. Wkly Epidemiol Rec. 2024;99(28):363–80. Available from: https://www.who.int/publications/i/item/who-wer9928-363-380.
Wolle MA, Muñoz BE, Mkocha H, West SK. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Ophthalmology. 2009;116(2):243–7. doi: https://doi.org/10.1016/j.ophtha.2008.09.011.
WHO. Report of the 4th global scientific meeting on trachoma: Geneva, 27–29 November 2018. Geneva: WHO; 4 June 2019. Available from: https://www.who.int/publications/i/item/who-htm-ntd-pct-2019.03.
Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016;14(6):385–400. doi: https://doi.org/10.1038/nrmicro.2016.30.
Solomon AW, Burton MJ, Gower EW, Harding-Esch EM, Oldenburg CE, Taylor HR et al. Trachoma. Nat Rev Dis Primers. 2022;8(1):32. doi: https://doi.org/10.1038/s41572-022-00359-5.
Habtamu E, Wondie T, Aweke S, Tadesse Z, Zerihun M, Zewdie Z et al. Trachoma and relative poverty: a case-control study. PLoS Negl Trop Dis. 2015;9(11):e0004228. doi: https://doi.org/10.1371/journal.pntd.0004228.
Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire C, Freeman MC. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001605. doi: https://doi.org/10.1371/journal.pmed.1001605.
Last A, Versteeg B, Shafi Abdurahman O, Robinson A, Dumessa G, Abraham Aga M et al. Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: identifying potential routes of transmission. PLoS Negl Trop Dis. 2020;14(3):e0008120. doi: https://doi.org/10.1371/journal.pntd.0008120.
Miller K, Pakpour N, Yi E, Melese M, Alemayehu W, Bird M et al. Pesky trachoma suspect finally caught. Br J Ophthalmol. 2004;88(6):750–1. doi: https://doi.org/10.1136/bjo.2003.038661.
Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362(9379):198–204. doi: https://doi.org/10.1016/S0140-6736(03)13909-8.
Cowling CS, Liu BC, Snelling TL, Ward JS, Kaldor JM, Wilson DP. Australian trachoma surveillance annual report, 2013. Commun Dis Intell Q Rep. 2016;40(2):E255–66. doi: https://doi.org/10.33321/cdi.2016.40.21.
Taylor HR, Fox SS, Xie J, Dunn RA, Arnold ALMR, Keeffe JE. The prevalence of trachoma in Australia: the National Indigenous Eye Health Survey. Med J Aust. 2010;192(5):248–53. doi: https://doi.org/10.5694/j.1326-5377.2010.tb03501.x.
WHO Alliance for the Global Elimination of Trachoma. Progress report, 2019. Wkly Epidemiol Rec. 2020;95(30):349–60. Available from: https://iris.who.int/handle/10665/333443.
WHO. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: WHO; 28 January 2021. Available from: https://www.who.int/publications/i/item/9789240010352.
Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis. 2003;3(6):372–81. doi: https://doi.org/10.1016/s1473-3099(03)00659-5.
Liu B, Cowling C, Hayen A, Watt G, Mak DB, Lambert S et al. Relationship between community drug administration strategy and changes in trachoma prevalence, 2007 to 2013. PLoS Negl Trop Dis. 2016;10(7):e0004810. doi: https://doi.org/10.1371/journal.pntd.0004810.
Warren JM, Birrell AL. Trachoma in remote Indigenous Australia: a review and public health perspective. Aust N Z J Public Health. 2016;40(Suppl 1):S48–52. doi: https://doi.org/10.1111/1753-6405.12396.
Ewald DP, Hall GV, Franks CC. An evaluation of a SAFE-style trachoma control program in Central Australia. Med J Aust. 2003;178(2):65–8. doi: https://doi.org/10.5694/j.1326-5377.2003.tb05065.x.
Wright HR, Keeffe JE, Taylor HR. Barriers to the implementation of the SAFE strategy to combat hyperendemic trachoma in Australia. Ophthalmic Epidemiol. 2010;17(6):349–59. doi: https://doi.org/10.3109/09286586.2010.528135.
Communicable Diseases Network Australia (CDNA). CDNA national guidelines for the public health management of trachoma. Canberra: Australian Government Department of Health, Disability and Ageing, CDNA; 31 January 2014. Available from: https://www.health.gov.au/sites/default/files/documents/2020/02/trachoma-cdna-national-guidelines-for-public-health-units.pdf.
WHO. Trachoma control: a guide for programme managers. Geneva: WHO; 20 July 2006. Available from: https://www.who.int/publications/i/item/9241546905.
The National Trachoma Surveillance and Reporting Unit. Australian Trachoma Surveillance Report 2021. Sydney: University of New South Wales, The Kirby Institute, WHO Collaborating Centre in Neglected Tropical Diseases; 2022. Available from: https://www.kirby.unsw.edu.au/sites/default/files/documents/TRACHOMA_2021.pdf.
Solomon AW, Kello AB, Bangert M, West SK, Taylor HR, Tekeraoi R et al. The simplified trachoma grading system, amended. Bull World Health Organ. 2020;98(10):698–705. doi: https://doi.org/10.2471/BLT.19.248708.
Dirani M, Keel S, Foreman J, van Wijngaarden P, Taylor HR. Prevalence of trachomatous trichiasis in Australia: the National Eye Health Survey. Clin Exp Ophthalmol. 2018;46(1):13–7. doi: https://doi.org/10.1111/ceo.13003.
Wolle MA, Muñoz BE, Naufal F, Kashaf MS, Mkocha H, West SK. Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania. PLoS Negl Trop Dis. 2021;15(11):e0009914. doi: https://doi.org/10.1371/journal.pntd.0009914.
Published
How to Cite
License
Copyright (c) 2026 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
